This study will evaluate the safety and effectiveness of an investigational drug for multiple types of advanced cancer that haven't responded to treatment and have spread to other parts of the body (metastatic).
Participants whose metastatic cancer can't be treated with standard treatments or has failed to respond to standard treatments are sought for this study of an investigational drug. We are studying the safety of the investigational drug and whether it stops the cancer from progressing.
What we're hoping for
We hope that the investigational drug will safely stop advanced cancer from progressing.
ClinicalTrials.gov Identifier: NCT03742895